We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · September 24, 2020

Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome

Hepatology (Baltimore, Md.)

 

Additional Info

Hepatology (Baltimore, Md.)
Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome
Hepatology 2020 Sep 01;[EPub Ahead of Print], S Piano, C Gambino, E Vettore, V Calvino, M Tonon, P Boccagni, E Gringeri, G Germani, P Burra, U Cillo, P Angeli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading